Harvest Management LLC Pardes Biosciences, Inc. Transaction History

Harvest Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 20, 2023	SELL	$1.4 - $1.95 $35,000 - $48,750	-25,000 Reduced 65.04%	13,435 $24,000
Q1 2023 May 15, 2023	BUY	$1.21 - $2.22 $3,188 - $5,849	2,635 Added 7.36%	38,435 $50,000
Q4 2022 Feb 14, 2023	SELL	$0.85 - $1.69 $2,465 - $4,901	-2,900 Reduced 7.49%	35,800 $60,000
Q2 2022 Aug 15, 2022	SELL	$2.84 - $8.57 $33,168 - $100,089	-11,679 Reduced 23.18%	38,700 $119,000
Q1 2022 May 16, 2022	SELL	$5.64 - $15.64 $112,800 - $312,800	-20,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$9.8 - $17.02 $196,000 - $340,400	20,000 New	20,000 $327,000

5.23M

Ticker PRDS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,320,900
Description
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...

Get notified when there are updates to the investment portfolio of Harvest Management LLC, based on Form 13F filings with the SEC.

Stay updated on Harvest Management LLC with notifications on news.